Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.
about
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE studyBleeding risk stratification in an era of aggressive management of acute coronary syndromesValidity of a PCI Bleeding Risk Score in patient subsets stratified for body mass indexWarfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk.BLEED-Myocardial Infarction Score: Predicting mid-term post-discharge bleeding events.Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients.Antiplatelet agents for the treatment and prevention of atherothrombosis.Prediction models for intracranial hemorrhage or major bleeding in patients on antiplatelet therapy: a systematic review and external validation study.Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED.Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry.Prospective assessment of a palliative care tool to predict one-year mortality in patients with acute coronary syndrome.Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.Temporal trends in ischemic and hemorrhagic strokes in Northern Italy: results from the cardiovascular monitoring unit in Northern Italy population-based register, 1998-2004.Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients.To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
P2860
Q34007717-258F0444-C0CE-495C-A613-C56BDEE07ED9Q34531925-34B8B51C-6A9E-4EA5-A68C-EC73AD49F09AQ34574018-862353CD-D368-41CF-911D-8D799C1A62E1Q35137974-FDEAB41F-F8F7-4012-B686-71567577AD4CQ36872957-F0F61599-404E-4501-AE25-692C6F3B00A5Q36952116-745FDC6A-C2E4-45B5-A08C-643A5BF6761AQ37538067-978D8047-1C2F-429A-8FCF-E76138CFD32AQ37948506-24CEF4F3-EDCC-4A52-9AE2-22056D02AA92Q38632127-0B22ED19-3268-41FC-B9DA-154611F5BDEDQ38645998-2A6442F7-23D2-418F-AF64-3E706F2EFE6FQ39428436-B9AC671E-AC86-40E6-873D-3AA6EC7ACF14Q39994225-1068B9A9-939D-4234-9958-CF03D043BA5AQ41191159-6EB3D8D9-870D-49DE-9D25-134AD8BD4B61Q43726201-DB1EE8A3-9B09-40EB-A6DE-FF3893AC1C93Q45206757-8BA43D8E-F6B1-4145-9090-76E99106DE73Q47676989-8D81476B-C3E1-48BC-82BB-315D2C14EC8BQ47685113-EB915941-70C8-4903-B1A7-2F6487B82390Q48761175-DC55D011-D9B1-43D1-9308-166611DE86D8Q49832828-A27E18F6-23A0-4BF5-BC66-88720A784AE3Q53973148-D5555A1E-37D3-4E67-B367-9F1FC910AEB3Q55425237-042609C8-EFB6-4DDE-8275-68A1A077E155
P2860
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk score to predict serious ...... r at risk of atherothrombosis.
@ast
Risk score to predict serious ...... r at risk of atherothrombosis.
@en
type
label
Risk score to predict serious ...... r at risk of atherothrombosis.
@ast
Risk score to predict serious ...... r at risk of atherothrombosis.
@en
prefLabel
Risk score to predict serious ...... r at risk of atherothrombosis.
@ast
Risk score to predict serious ...... r at risk of atherothrombosis.
@en
P2093
P2860
P50
P356
P1476
Risk score to predict serious ...... r at risk of atherothrombosis.
@en
P2093
Deepak L Bhatt
Gabriel Baron
Gregory Ducrocq
Joshua S Wallace
Mark J Alberts
Peter W F Wilson
REACH Investigators
Ralph B D'Agostino
P2860
P304
P356
10.1093/EURHEARTJ/EHQ021
P577
2010-02-24T00:00:00Z